NewsMarkets

Business

Eli Lilly CEO Reveals Foundayo Adoption and New Houston Plant

CEO Dave Ricks reports that one-third of new patients take the GLP-1 pill Foundayo while breaking ground on a $6.5 billion manufacturing facility in Houston.

2 publishers · 3 articles · first seen 21 Sept 2026 · updated 2h ago

How it unfolded

Every source in the order it published.

  1. CNBCEli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production
  2. QuartzLilly's Foundayo pill wins over a third of new patients, CEO says
  3. QuartzLillys Foundayo-Pille gewinnt mehr als ein Drittel neuer Patienten, sagt der CEO.

Sources

Every article we clustered into this story. Headlines link to the publisher.

  1. Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production CNBC ·
  2. Lilly's Foundayo pill wins over a third of new patients, CEO says Quartz
  3. Lillys Foundayo-Pille gewinnt mehr als ein Drittel neuer Patienten, sagt der CEO. Quartz

In this story

  • Eli Lilly
  • Novo
  • Dave Ricks
  • Foundayo
  • Houston

Related stories